Literature DB >> 18212495

Otologic manifestations of Hunter syndrome and their relationship with speech development.

Yang-Sun Cho1, Joon Ho Kim, Tae Wook Kim, Soo Chan Chung, Son-A Chang, Dong-Kyu Jin.   

Abstract

The excessive storage of mucopolysaccharide in Hunter syndrome leads to various otologic manifestations. We interviewed 19 patients with Hunter syndrome to assess their otologic problems, and conducted audiologic tests and temporal bone CT. Patients with the intermediate or severe form exhibited severe speech delay by more than 2 years (12/14 patients). However, in patients with the mild form (5/5), speech development was not much disturbed (2/5), although otoscopic findings were similar. The hearing threshold determined by the auditory brainstem response differed significantly between the mild and intermediate/severe forms (p < 0.05). Therefore, patients with the mild form may benefit from active otologic intervention such as VT insertion, amplification, and speech therapy. (c) 2008 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2008        PMID: 18212495     DOI: 10.1159/000113511

Source DB:  PubMed          Journal:  Audiol Neurootol        ISSN: 1420-3030            Impact factor:   1.854


  5 in total

Review 1.  Behavioural phenotypes of the mucopolysaccharide disorders: a systematic literature review of cognitive, motor, social, linguistic and behavioural presentation in the MPS disorders.

Authors:  E M Cross; D J Hare
Journal:  J Inherit Metab Dis       Date:  2013-02-06       Impact factor: 4.982

Review 2.  ENT and mucopolysaccharidoses.

Authors:  Pier Marco Bianchi; Renato Gaini; Silvano Vitale
Journal:  Ital J Pediatr       Date:  2018-11-16       Impact factor: 2.638

Review 3.  Assessing the impact of the five senses on quality of life in mucopolysaccharidoses.

Authors:  Roberto Giugliani; Paul Harmatz; Shuan-Pei Lin; Maurizio Scarpa
Journal:  Orphanet J Rare Dis       Date:  2020-04-19       Impact factor: 4.123

4.  A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II.

Authors:  Elsa G Shapiro; Kyle Rudser; Alia Ahmed; Robert D Steiner; Kathleen A Delaney; Brianna Yund; Kelly King; Alicia Kunin-Batson; Julie Eisengart; Chester B Whitley
Journal:  Mol Genet Metab Rep       Date:  2016-04-01

5.  An online survey of burden of illness in families with mucopolysaccharidosis type II children in the United States.

Authors:  Therese Conner; Francesca Cook; Vivian Fernandez; Vanessa Rangel-Miller
Journal:  Mol Genet Metab Rep       Date:  2019-08-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.